Missoula, MTNCT06706765Now EnrollingIRB Ready

Refractory Chronic Cough Clinical Trial in Missoula, MT

Access cutting-edge refractory chronic cough treatment through this clinical trial at a research site in Missoula. Study-provided care at no cost to qualified participants.

Sponsored by University of Montana

Quick Self-Assessment

See if you qualify for this Missoula location

Preparing your pre-screening questions…

Expert Care in Missoula

Access refractory chronic cough specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related refractory chronic cough treatment provided free

Apply for This Missoula Location

Check if you qualify for this refractory chronic cough clinical trial in Missoula, MT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Missoula

    Convenient for MT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Missoula site if eligible
  4. 4Begin participation

About This Refractory Chronic Cough Study in Missoula

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Sponsor: University of Montana

Who Can Participate

Inclusion Criteria

At least 18 years old
Predominantly dry cough for at least 8 weeks
Evaluated and treated by at least one physician for cough
Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
Access to a computer or tablet that includes a camera and able to use the device independently
Reliable internet access
Willing to agree to maintain confidentiality of personal information (including names) related to others in the study

Exclusion Criteria

Under age 18
Coughing up blood
Current smoker of any substance
History of smoking or 10 or more years
Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and will not exclude them from the study.)
Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
Complaints of swallowing difficulty
Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
Prior BCST treatment with an SLP or respiratory therapist

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Missoula?

Yes, this clinical trial (NCT06706765) has an active research site in Missoula, MT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Refractory Chronic Cough Treatment Options in Missoula, MT

If you're searching for refractory chronic cough treatment options in Missoula, MT, this clinical trial (NCT06706765) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Missoula research site is actively enrolling participants for this clinical trial. You'll receive care from experienced refractory chronic cough specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all refractory chronic cough clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Missoula, MT

See all rheumatoid arthritis clinical trials recruiting in Missoula — not just this study.

Browse Rheumatoid Arthritis Trials in Missoula →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Missoula?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Missoula, MT